Narcisa Mesaros

Narcisa MESAROS, MD, is an experienced medical professional currently serving as VP Medical Science & Strategy and Therapeutic Area Head for Vaccines & Infectious and Respiratory Diseases at PPD since October 2022. Previously, Narcisa MESAROS held the position of Clinical Franchise Lead for Bacterial Vaccines and the Ebola program at The Janssen Pharmaceutical Companies of Johnson & Johnson from September 2021 to September 2022. Prior to that, from September 2006 to August 2021, Narcisa MESAROS worked at GSK in various roles, including Clinical and Epidemiology R&D Project Lead for DTP and dTap, as well as Late Clinical R&D Lead for cancer immunotherapy. Earlier experience includes a research assistant role at Université catholique de Louvain, focusing on antibiotic resistance, and positions at the de Duve Institute and Spital Orasenesc Campeni-Alba. Narcisa MESAROS earned a Diplome d’etudes specialises in Biomedical Sciences - Biochemistry and Molecular Biology from Université catholique de Louvain and a medical degree from the University of Medicine and Pharmacy "Iuliu Hațieganu."